Glenmede Investment Management, LP Elanco Animal Health Inc Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Glenmede Investment Management, LP holds 73,180 shares of ELAN stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
73,180
Previous 31,579
131.74%
Holding current value
$1.54 Million
Previous $451 Million
99.67%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELAN
# of Institutions
460Shares Held
491MCall Options Held
780KPut Options Held
1.08M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD31.5MShares$665 Million0.39% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...